Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-37,700
Closed -$610K 1294
2020
Q2
$610K Sell
37,700
-160,400
-81% -$2.48M ﹤0.01% 1033
2020
Q1
$2.5M Buy
198,100
+91,900
+87% +$2.32M 0.01% 686
2019
Q4
$2.81M Buy
106,200
+15,200
+17% +$391K 0.01% 751
2019
Q3
$2.31M Buy
91,000
+21,700
+31% +$571K 0.01% 832
2019
Q2
$1.86M Sell
69,300
-18,700
-21% -$457K 0.01% 859
2019
Q1
$1.95M Buy
88,000
+5,300
+6% +$111K 0.01% 857
2018
Q4
$1.52M Buy
82,700
+26,500
+47% +$504K 0.01% 876
2018
Q3
$1.14M Sell
56,200
-8,500
-13% -$174K ﹤0.01% 1009
2018
Q2
$1.34M Buy
64,700
+21,600
+50% +$428K 0.01% 938
2018
Q1
$801K Buy
+43,100
New +$791K ﹤0.01% 1054
2016
Q3
Sell
-4,600
Closed -$55K 1211
2016
Q2
$55K Buy
4,600
+500
+12% +$6.04K ﹤0.01% 1293
2016
Q1
$48K Buy
+4,100
New +$44.4K ﹤0.01% 1245

Other funds holding CAE

Axa's CAE Position: Q3 2020 in Review

Axa sold out of CAE Inc (CAE) in Q3 2020, closing a stake of 37,700 shares — an estimated $610K sold.

Axa first reported a position in CAE in Q1 2016 and held it in 12 quarters. The position peaked at $2.81M in Q4 2019. 165 funds tracked by Wall St. Rank hold CAE as of Q3 2020.

  • Axa reported no remaining CAE Inc position as of Q3 2020 after selling out during the quarter.
  • Axa sold 37,700 CAE Inc shares in Q3 2020, an estimated $610K.
  • Axa first reported a position in CAE Inc in Q1 2016 and held it in 12 quarters.
  • Axa's CAE Inc position peaked at $2.81M in Q4 2019.
  • 165 funds tracked by Wall St. Rank held CAE Inc as of Q3 2020.

Based on Axa's 13F filing for Q3 2020, filed 13 Nov 2020.